The response of hepatitis B vaccination on seronegative adults with different vaccination schedules

References

• Ganem D, Prince AM. Hepatitis B virus infection-natural history and clinical consequences. N Engl J Med 2004. 350:1118-29; PMID:15014185; http://dx.doi.org/10.1056/NEJMra031087
   PubMed Web of Science ®Google Scholar
• Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and Current and emerging prevention and control measures. J Viral Hepat 2004. 11:97-107; PMID:14996343; http://dx.doi.org/10.1046/j.1365-2893.2003.00487.x
   PubMed Web of Science ®Google Scholar
• Goldstein ST, Zhou F, Hadler SC, Bell BP, Mast EE, Margolis HS. A mathematical model to estimate global Hepatitis B disease burden and vaccination impact. Int J Epidemiol 2005; 34:1329-39.
   PubMed Web of Science ®Google Scholar
• Ganczak M, Szych Z, Korzen M. Preoperative Vaccination for HBV at Polish hospitals as a possible public health tool to limit the spread of the epidemic: a cross-sectional study. Vaccine 2009. 27:3969-74; PMID:19389444; http://dx.doi.org/10.1016/j.vaccine.2009.04.042
   PubMedGoogle Scholar
• World Health Organization. Hepatitis B. http:www.who.int/Mediacentre/factsheetTs/fs204.Geneva, Switzerland: Taylor & Francis, 2000. Acceessed 2 June 2010.
   Google Scholar
• Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y et al. Epidemiological serosurvey of Hepatitis B in China – declining HBV prevalence due to Hepatitis vaccination. Vaccine 2013. 3(Suppl9):J21-8; PMID:23948229; http://dx.doi.org/10.1016/j.vaccine.2013.08.012
   PubMedGoogle Scholar
• Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y et al. Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in China. J Infect Dis 2009. 200:39-47; PMID:19469708; http://dx.doi.org/10.1086/599332
   PubMed Web of Science ®Google Scholar
• Lu FM, Zhuang H. Management of hepatitis B in China. Chin Med J (Engl), 2009. 122:3-4; PMID:19187608
   PubMed Web of Science ®Google Scholar
• Chang MH, Hadzic D, Rouassant SH, Jonas M, Kohn IJ, Negro F, Roberts E, Sibal A. Acute and chronic hepatitis: working group report of the second world Congress of Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr 2004; 39(Suppl 2):S584-8.
   PubMed Web of Science ®Google Scholar
• Cindy M. Williams I, Mast EE, Wang SA, Finelli L, Wasley A, Neitzel SM, Ward JW; Centers for Disease Control and Prevention (CDC). Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Morb Mortal Wkly Rep 2008. 57:1-20; PMID:18802412
   PubMedGoogle Scholar
• Shen LZ, Yao J. The strategy of Hepatitis b vaccine booster. Zhejiang Prev Med 2011; 12:22-5.
   Google Scholar
• Ni YH, Chang MH, Wu JF, Hsu HY, Chen HL, Chen DS. Minimization of hepatitis B infection by a 25-year universal vaccination program. J Hepatol 2012; 57:730-5.
   PubMed Web of Science ®Google Scholar
• Qi XQ, Wang Y. Chinese hepatitis B viral serum epidemiology investigation report. Beijing: Taylor & Francis; 2011. 49-54.
   Google Scholar
• Daniels D, Grytdal S, Wasley A, Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD, TB Prevention, CDC. Surveillance for acute viral hepatitis - United States, 2007. MMWR 2009; 58(SS03):1-27; PMID: 19478727
   Google Scholar
• Mast EE, Mahoney FJ, Alter MJ. Progress toward elimination of hepatitis B virus transmission in the United States. Vaccine 1998. 16(Supple):S48-S51; PMID:9915035
   PubMed Web of Science ®Google Scholar
• Zuckerman J, Langer B. Hepatitis B vaccination in a school age population:a feasibility study. J Med Virol, 2005.76:47-54; PMID:15778966
   PubMedGoogle Scholar
• Bonanni P. Implementation in Italy of a universal vaccination programme against hepatitis B. Vaccine, 1995; 13(Supple):S68-71; PMID:7571837
   PubMed Web of Science ®Google Scholar
• Zhang XC, Pang XH, Zhang W, Han LL, Lin CY. Prevalence of hepatitis B in Chaoyang district, Beijing in 2010. Chinese J Prevent Med 2012; 46:623-6.
   Google Scholar
• Dun Z, Fu JY, Wang YZ, Dong SL, Xu RH, Zhao YF. Investigation on the strategy of increasing adults’ inoculation rate of hepatitis B vaccine. Modern Preventive Medicine 2008, 35(11):2135-8.
   Google Scholar
• Lian YM. Report on the innovation of china's social administration. Report on the Innovation of China's Social Administration 2012. Beijing: Taylor & Francis. 121-143.
   Google Scholar
• Man J, Ni JZ , Wang XN, Wang JY, Xie GL. Clinic STD patients of floating population behavior survey. J QiQiHaR University Med, 2011. 17:2824-5.
   Google Scholar
• Shi JG, Zhang T. Analysis epidemic characteristics of infectious diseases in floating population in Kunshan municipality during 1997∼2003. Occup Health 2005; 1, 66-7.
   Google Scholar
• Zhang W, Lin CY, Han LL. Different dose domestic recombinant yeast hepatitis b vaccine in adults immunization effect and influence factors. Chin J Epidemiol 2010. 31:767-70.
   Google Scholar
• Rendi-Wagner P, Kundi M, Stemberger H, Wiedermann G, Holzmann H, Hofer M, Wiesinger K, Kollaritsch H. Antibody-response to three recombinant hepatitis B vaccines: comparative evaluation of multicenter Travel-clinic based experience. Vaccine2001.19:2055-66.
   PubMed Web of Science ®Google Scholar
• Yuan JM, Zhang JA. The effect of two hepatitis b immunization programs. Nursing Journal of Chinese People's Liberation Army 2004. 10:67-68.
   Google Scholar
• Tran TQ, Grimes CZ, Lai D, Troisi CL, Hwang LY. Effect of age and frequency of injections on immune response to hepatitis B vaccination in drug users. Vaccine 2012.30(2):342-9; PMID:22075088
   PubMed Web of Science ®Google Scholar
• Saltoglu N, Inal AS, Tasova Y, Kandemir O. Comparison of the accelerated and classic vaccination schedules against Hepatitis B: three-week Hepatitis B vaccination schedule provides immediate and protective immunity. Ann Clin Microbiol Antimicrob 2003; 2:10; PMID:14622443
   PubMedGoogle Scholar
• McMahon BJ, Bruden DL, Petersen KM, Bulkow LR,Parkinson AJ, Nainan O, Khristova M, Zanis C, Peters H, Margolis HS. Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up. Ann Intern Med 2005; 142:333-41; PMID:15738452; http://dx.doi.org/10.7326/0003-4819-142-5-200503010-00008
   PubMed Web of Science ®Google Scholar
• McMahon BJ, Dentinger CM, Bruden D, Zanis C, Peters H, Hurlburt D, Hurlburt D, Bulkow L, Fiore AE, Bell BP, Hennessy TW. Antibody levels and protection after hepatitis B vaccine: results of a 22-year follow-up study and response to a booster dose. J Infect Dis 2009. 200:1390-6; PMID:19785526; http://dx.doi.org/10.1086/606119
   PubMed Web of Science ®Google Scholar
• Mast EE, Weinbaum CM, Fiore AE, Alter MJ, Bell BP, Finelli L, Rodewald LE, Douglas JM Jr, Janssen RS, Ward JW. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Recomm Rep 2006; 55:1-33.
   PubMedGoogle Scholar
• Hernandez-Bernal F, Aguilar-Betancourt A, Aljovin V, Arias G, Valenzuela C, de Alejo KP, Hernández K, Oquendo O, Figueredo N, Figueroa N ,et al. Comparison of four recombinant hepatitis B vaccines applied on an accelerated schedule in healthy adults. Hum Vaccin 2011. 7(10):1026-36; PMID:21941089
   PubMed Web of Science ®Google Scholar
• Rebedea I, Diaconescu IG, Bach D, Bartelsen O, Arndtz N. Comparison of thiomersal-free and thiomersal-containing formulations of a recombinant hepatitis B vaccine (Hepavax-Gene) in healthy adults. Vaccine 2006; 24(25):5320-6; PMID:16707195; http://dx.doi.org/10.1016/j.vaccine.2006.04.018
   PubMedGoogle Scholar
• Xu F, He F, Zhou BQ, Zhao QY, Yan R. Observation on immunization effect of hepatitis B vaccine in adults by different dosages and schedules. Dis Surveill 2013; 28(1):38-41.
   Google Scholar
• Shaw Jr FE, Guess HA, Roets JM, Mohr FE, Coleman PJ, Mandel EJ, Roehm Jr RR, Talley WS, Hadler SC. Effect of anatomic injection site, age and smoking on the immune response to hepatitis B vaccination. Vaccine, 1989, 7(5): 425-430.
   Google Scholar
• Kubba AK, Taylor P, Graneek B, Strobel S. Non-responders to hepatitis B vaccination: a review. Commun Dis Public Health 2003; 6(2):106-12.
   PubMedGoogle Scholar